UK team joins race to develop blood test for Alzheimer's disease
This article was originally published in Clinica
Executive Summary
A team of UK researchers is joining the race to develop a blood-based test for Alzheimer's disease (AD), with two biomarkers that it says could diagnose the disease up to two years before current clinical diagnostic methods. It may also provide a means of monitoring ongoing disease progress, and may prove useful in monitoring clinical trials of AD drugs, said the researchers, led by Simon Lovestone, at Kings College London's MRC Centre for Neurodegeneration Research.